{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T20:17:48Z","timestamp":1790194668443,"version":"4.1.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2023,3,19]],"date-time":"2023-03-19T00:00:00Z","timestamp":1679184000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,3,19]],"date-time":"2023-03-19T00:00:00Z","timestamp":1679184000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100009053","name":"The Wellcome Trust DBT India Alliance","doi-asserted-by":"publisher","award":["BT\/MED\/30\/SP11290\/2015"],"award-info":[{"award-number":["BT\/MED\/30\/SP11290\/2015"]}],"id":[{"id":"10.13039\/501100009053","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Med Oncol"],"DOI":"10.1007\/s12032-023-01984-0","type":"journal-article","created":{"date-parts":[[2023,3,26]],"date-time":"2023-03-26T21:45:58Z","timestamp":1679867158000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["PI3K\/AKT\/mTOR inhibitors as potential extracellular matrix modulators for targeting EMT subtype gastric tumors"],"prefix":"10.1007","volume":"40","author":[{"given":"Ponmathi","family":"Panneerpandian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0533-3181","authenticated-orcid":false,"given":"Kumaresan","family":"Ganesan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,3,19]]},"reference":[{"key":"1984_CR1","doi-asserted-by":"publisher","first-page":"3686","DOI":"10.3390\/ijms21103686","volume":"21","author":"E Andreuzzi","year":"2020","unstructured":"Andreuzzi E, Capuano A, Poletto E, et al. Role of extracellular matrix in gastrointestinal cancer-associated angiogenesis. Int J Mol Sci. 2020;21:3686.","journal-title":"Int J Mol Sci"},{"key":"1984_CR2","doi-asserted-by":"publisher","first-page":"160","DOI":"10.3389\/fmolb.2019.00160","volume":"6","author":"E Henke","year":"2020","unstructured":"Henke E, Nandigama R, Erg\u00fcn S. Extracellular matrix in the tumor microenvironment and its impact on cancer therapy. Front Mol Biosci. 2020;6:160.","journal-title":"Front Mol Biosci"},{"key":"1984_CR3","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1038\/s41392-021-00544-0","volume":"6","author":"J Huang","year":"2021","unstructured":"Huang J, Zhang L, Wan D, et al. Extracellular matrix and its therapeutic potential for cancer treatment. Signal Transduct Target Ther. 2021;6:153.","journal-title":"Signal Transduct Target Ther"},{"key":"1984_CR4","doi-asserted-by":"publisher","first-page":"1482","DOI":"10.3389\/fonc.2019.01482","volume":"9","author":"Z Elgundi","year":"2020","unstructured":"Elgundi Z, Papanicolaou M, Major G, et al. Cancer metastasis: the role of the extracellular matrix and the heparan sulfate proteoglycan perlecan. Front Oncol. 2020;9:1482.","journal-title":"Front Oncol"},{"key":"1984_CR5","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1038\/nature13480","volume":"513","author":"AJ Bass","year":"2014","unstructured":"Bass AJ, Thorsson V, Shmulevich I, et al. Comprehensive molecular characterization of gastric adenocarcinoma. Nature. 2014;513:202\u20139. https:\/\/doi.org\/10.1038\/nature13480.","journal-title":"Nature"},{"key":"1984_CR6","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian A, Tamayo P, Mootha VK, et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci USA. 2005;102:15545\u201350. https:\/\/doi.org\/10.1073\/pnas.0506580102.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1984_CR7","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkz849","author":"X Shao","year":"2020","unstructured":"Shao X, Taha IN, Clauser KR, et al. MatrisomeDB: the ECM-protein knowledge database. Nucl Acids Res. 2020. https:\/\/doi.org\/10.1093\/nar\/gkz849.","journal-title":"Nucl Acids Res"},{"key":"1984_CR8","doi-asserted-by":"publisher","DOI":"10.1186\/gb-2006-7-10-r93","author":"DM Levine","year":"2006","unstructured":"Levine DM, Haynor DR, Castle JC, et al. Pathway and gene-set activation measurement from mRNA expression data: the tissue distribution of human pathways. Genome Biol. 2006. https:\/\/doi.org\/10.1186\/gb-2006-7-10-r93.","journal-title":"Genome Biol"},{"key":"1984_CR9","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1000676","author":"CH Ooi","year":"2009","unstructured":"Ooi CH, Ivanova T, Wu J, et al. Oncogenic pathway combinations predict clinical prognosis in gastric cancer. PLoS Genet. 2009. https:\/\/doi.org\/10.1371\/journal.pgen.1000676.","journal-title":"PLoS Genet"},{"key":"1984_CR10","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1038\/75556","volume":"25","author":"M Ashburner","year":"2000","unstructured":"Ashburner M, Ball CA, Blake JA, et al. Gene ontology: tool for the unification of biology. Nat Genet. 2000;25:25\u20139.","journal-title":"Nat Genet"},{"key":"1984_CR11","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2105-14-128","author":"EY Chen","year":"2013","unstructured":"Chen EY, Tan CM, Kou Y, et al. Enrichr: interactive and collaborative HTML5 gene list enrichment analysis tool. BMC Bioinform. 2013. https:\/\/doi.org\/10.1186\/1471-2105-14-128.","journal-title":"BMC Bioinform"},{"key":"1984_CR12","doi-asserted-by":"publisher","unstructured":"Sz\u00e1sz AM, L\u00e1nczky A, Nagy \u00c1 et al (2016) Cross-validation of survival associated biomarkers in gastric cancer using transcriptomic data of 1065 patients. Oncotarget 7:49322\u201349333. https:\/\/doi.org\/10.18632\/oncotarget.10337","DOI":"10.18632\/oncotarget.10337"},{"key":"1984_CR13","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkn300","author":"V Gotea","year":"2008","unstructured":"Gotea V, Ovcharenko I. DiRE: identifying distant regulatory elements of co-expressed genes. Nucl Acids Res. 2008. https:\/\/doi.org\/10.1093\/nar\/gkn300.","journal-title":"Nucl Acids Res"},{"key":"1984_CR14","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1002\/0471143030.cb0403s69","volume":"69","author":"JG Donaldson","year":"2015","unstructured":"Donaldson JG. Immunofluorescence staining. Curr Protoc Cell Biol. 2015;69:431\u20137. https:\/\/doi.org\/10.1002\/0471143030.cb0403s69.","journal-title":"Curr Protoc Cell Biol"},{"key":"1984_CR15","doi-asserted-by":"publisher","first-page":"1590","DOI":"10.1002\/mc.22614","volume":"56","author":"S Tamilzhalagan","year":"2017","unstructured":"Tamilzhalagan S, Rathinam D, Ganesan K. Amplified 7q21-22 gene MCM7 and its intronic miR-25 suppress COL1A2 associated genes to sustain intestinal gastric cancer features. Mol Carcinog. 2017;56:1590\u2013602. https:\/\/doi.org\/10.1002\/mc.22614.","journal-title":"Mol Carcinog"},{"key":"1984_CR16","doi-asserted-by":"publisher","unstructured":"Pickup MW, Mouw JK, Weaver VM (2014) The extracellular matrix modulates the hallmarks of cancer. EMBO Rep. https:\/\/doi.org\/10.15252\/embr.201439246","DOI":"10.15252\/embr.201439246"},{"key":"1984_CR17","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3390\/cells9020394","volume":"9","author":"AM Moreira","year":"2020","unstructured":"Moreira AM, Pereira J, Melo S, et al. The extracellular matrix: an accomplice in gastric cancer development and progression. Cells. 2020;9:394.","journal-title":"Cells"},{"key":"1984_CR18","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1207886","author":"N Jinawath","year":"2004","unstructured":"Jinawath N, Furukawa Y, Hasegawa S, et al. Comparison of gene-expression profiles between diffuse- and intestinal-type gastric cancers using a genome-wide cDNA microarray. Oncogene. 2004. https:\/\/doi.org\/10.1038\/sj.onc.1207886.","journal-title":"Oncogene"},{"key":"1984_CR19","doi-asserted-by":"publisher","unstructured":"Yap YS, McPherson JR, Ong CK et al (2014) The NF1 gene revisited\u2014from bench to bedside. Oncotarget. https:\/\/doi.org\/10.18632\/oncotarget.2194","DOI":"10.18632\/oncotarget.2194"},{"key":"1984_CR20","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gks1111","author":"W Yang","year":"2013","unstructured":"Yang W, Soares J, Greninger P, et al. Genomics of drug sensitivity in cancer (GDSC): a resource for therapeutic biomarker discovery in cancer cells. Nucl Acids Res. 2013. https:\/\/doi.org\/10.1093\/nar\/gks1111.","journal-title":"Nucl Acids Res"},{"key":"1984_CR21","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1038\/nature11003","volume":"483","author":"J Barretina","year":"2012","unstructured":"Barretina J, Caponigro G, Stransky N, et al. The cancer cell line encyclopedia enables predictive modelling of anticancer drug sensitivity. Nature. 2012;483:603\u20137. https:\/\/doi.org\/10.1038\/nature11003.","journal-title":"Nature"},{"key":"1984_CR22","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.tibtech.2015.01.004","volume":"33","author":"R Malik","year":"2015","unstructured":"Malik R, Lelkes PI, Cukierman E. Biomechanical and biochemical remodeling of stromal extracellular matrix in cancer. Trends Biotechnol. 2015;33:230\u20136.","journal-title":"Trends Biotechnol"},{"key":"1984_CR23","doi-asserted-by":"publisher","first-page":"3028","DOI":"10.3390\/ijms19103028","volume":"19","author":"C Walker","year":"2018","unstructured":"Walker C, Mojares E, Del R\u00edo HA. Role of extracellular matrix in development and cancer progression. Int J Mol Sci. 2018;19:3028.","journal-title":"Int J Mol Sci"},{"key":"1984_CR24","doi-asserted-by":"publisher","first-page":"5120","DOI":"10.1038\/s41467-020-18794-x","volume":"11","author":"J Winkler","year":"2020","unstructured":"Winkler J, Abisoye-Ogunniyan A, Metcalf KJ, Werb Z. Concepts of extracellular matrix remodelling in tumour progression and metastasis. Nat Commun. 2020;11:5120.","journal-title":"Nat Commun"},{"key":"1984_CR25","doi-asserted-by":"publisher","DOI":"10.1113\/JP277195","author":"R Aktar","year":"2019","unstructured":"Aktar R, Peiris M, Fikree A, et al. A novel role for the extracellular matrix glycoprotein-Tenascin-X in gastric function. J Physiol. 2019. https:\/\/doi.org\/10.1113\/JP277195.","journal-title":"J Physiol"},{"key":"1984_CR26","doi-asserted-by":"publisher","DOI":"10.7717\/peerj.9123","author":"Z Li","year":"2020","unstructured":"Li Z, Liu Z, Shao Z, et al. Identifying multiple collagen gene family members as potential gastric cancer biomarkers using integrated bioinformatics analysis. PeerJ. 2020. https:\/\/doi.org\/10.7717\/peerj.9123.","journal-title":"PeerJ"},{"key":"1984_CR27","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1124\/pr.109.001289","volume":"61","author":"H J\u00e4rvel\u00e4inen","year":"2009","unstructured":"J\u00e4rvel\u00e4inen H, Sainio A, Koulu M, et al. Extracellular matrix molecules: potential targets in pharmacotherapy. Pharmacol Rev. 2009;61:198\u2013223.","journal-title":"Pharmacol Rev"},{"key":"1984_CR28","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.addr.2015.10.007","volume":"97","author":"AW Holle","year":"2016","unstructured":"Holle AW, Young JL, Spatz JP. In vitro cancer cell-ECM interactions inform in vivo cancer treatment. Adv Drug Deliv Rev. 2016;97:270\u20139.","journal-title":"Adv Drug Deliv Rev"},{"key":"1984_CR29","doi-asserted-by":"publisher","DOI":"10.2147\/OTT.S48883","author":"R Harisi","year":"2015","unstructured":"Harisi R, Jeney A. Extracellular matrix as target for antitumor therapy. Onco Targets Ther. 2015. https:\/\/doi.org\/10.2147\/OTT.S48883.","journal-title":"Onco Targets Ther"},{"key":"1984_CR30","doi-asserted-by":"publisher","first-page":"88","DOI":"10.3390\/jpm11020088","volume":"11","author":"N Subrahmanyam","year":"2021","unstructured":"Subrahmanyam N, Ghandehari H. Harnessing extracellular matrix biology for tumor drug delivery. J Pers Med. 2021;11:88.","journal-title":"J Pers Med"},{"key":"1984_CR31","doi-asserted-by":"publisher","first-page":"86","DOI":"10.3389\/fcell.2019.00086","volume":"7","author":"S Nallanthighal","year":"2019","unstructured":"Nallanthighal S, Heiserman JP, Cheon DJ. The role of the extracellular matrix in cancer stemness. Front Cell Dev Biol. 2019;7:86.","journal-title":"Front Cell Dev Biol"},{"key":"1984_CR32","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0090353","author":"JC Morris","year":"2014","unstructured":"Morris JC, Tan AR, Olencki TE, et al. Phase I study of GC1008 (Fresolimumab): a human anti-transforming growth factor-beta (TGF\u03b2) monoclonal antibody in patients with advanced malignant melanoma or renal cell carcinoma. PLoS ONE. 2014. https:\/\/doi.org\/10.1371\/journal.pone.0090353.","journal-title":"PLoS ONE"},{"key":"1984_CR33","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdu474","author":"E \u00c9lez","year":"2015","unstructured":"\u00c9lez E, Koc\u00e1kov\u00e1 I, H\u00f6hler T, et al. Abituzumab combined with cetuximab plus irinotecan versus cetuximab plus irinotecan alone for patients with KRAS wild-type metastatic colorectal cancer: the randomised phase I\/II POSEIDON trial. Ann Oncol. 2015. https:\/\/doi.org\/10.1093\/annonc\/mdu474.","journal-title":"Ann Oncol"},{"key":"1984_CR34","doi-asserted-by":"publisher","DOI":"10.1007\/s00228-018-2435-3","author":"CH Maden","year":"2018","unstructured":"Maden CH, Fairman D, Chalker M, et al. Safety, tolerability and pharmacokinetics of GSK3008348, a novel integrin \u03b1v\u03b26 inhibitor, in healthy participants. Eur J Clin Pharmacol. 2018. https:\/\/doi.org\/10.1007\/s00228-018-2435-3.","journal-title":"Eur J Clin Pharmacol"},{"key":"1984_CR35","doi-asserted-by":"publisher","DOI":"10.1038\/srep41541","author":"M Jang","year":"2017","unstructured":"Jang M, Koh I, Lee SJ, et al. Droplet-based microtumor model to assess cell-ECM interactions and drug resistance of gastric cancer cells. Sci Rep. 2017. https:\/\/doi.org\/10.1038\/srep41541.","journal-title":"Sci Rep"}],"container-title":["Medical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-023-01984-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12032-023-01984-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-023-01984-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,22]],"date-time":"2024-04-22T02:13:01Z","timestamp":1713751981000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12032-023-01984-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,19]]},"references-count":35,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2023,4]]}},"alternative-id":["1984"],"URL":"https:\/\/doi.org\/10.1007\/s12032-023-01984-0","relation":{},"ISSN":["1559-131X"],"issn-type":[{"value":"1559-131X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,19]]},"assertion":[{"value":"1 January 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 February 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 March 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}],"article-number":"120"}}